Sofosbuvir/Velpatasvir (SOF/VEL)-Based Regimens are Associated with Excellent Efficacy and a Significant Improvement of Patients-Reported Outcomes (PROs) across Patient Populations: From Non-Cirrhotics to Compensated Cirrhotics to Decompensated Cirrhotics
dc.contributor.author | Younossi, ZM | en_US |
dc.contributor.author | Stepanova, M | en_US |
dc.contributor.author | Feld, JJ | en_US |
dc.contributor.author | Zeuzem, S | en_US |
dc.contributor.author | Sulkowski, MS | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.contributor.author | Mangia, A | en_US |
dc.contributor.author | Charlton, MR | en_US |
dc.contributor.author | O'Leary, JG | en_US |
dc.contributor.author | Curry, MP | en_US |
dc.contributor.author | Nader, F | en_US |
dc.contributor.author | Henry, L | en_US |
dc.contributor.author | Hunt, S | en_US |
dc.date.accessioned | 2017-03-15T15:29:39Z | |
dc.date.issued | 2016-10 | en_US |
dc.date.submitted | 2017-01-04T08:25:51.077Z | |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/20699 | |
dc.description.sponsorship | Amer Assoc Study Liver Dis | en_US |
dc.format.extent | 12A - 12A | en_US |
dc.title | Sofosbuvir/Velpatasvir (SOF/VEL)-Based Regimens are Associated with Excellent Efficacy and a Significant Improvement of Patients-Reported Outcomes (PROs) across Patient Populations: From Non-Cirrhotics to Compensated Cirrhotics to Decompensated Cirrhotics | en_US |
dc.type | Conference Proceeding | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385493800024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 64 | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |
This item appears in the following Collection(s)
-
Centre for Immunobiology [922]